Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World J Clin Oncol. 2015;6(6):281–90.
Article PubMed PubMed Central Google Scholar
Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman M, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102(5):315–24.
Article PubMed PubMed Central Google Scholar
Vale DB, Silva MT, Discacciati MG, Polegatto I, Teixeira JC, Zeferino LC. Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country. PLoS ONE. 2021;16(5):e0251688.
Article CAS PubMed PubMed Central Google Scholar
Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping. J Gynecol Oncol. 2016;27(2):e21–e21.
Jentschke M, Soergel P, Hillemanns P. Importance of HPV genotyping for the screening, therapy and management of cervical neoplasias. Geburtshilfe Frauenheilkd. 2012;72(6):507–12.
Article CAS PubMed PubMed Central Google Scholar
World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. https://www.who.int/publications/i/item/9789240030824. Accessed 01 Feb 2023.
LaVigne AW, Triedman S, Randall TC, Trimble EL, Viswanathan AN. Cervical cancer in low and middle income countries: addressing barriers to radiotherapy delivery. Gynecol Oncol Rep. 2017;22:16–20.
Article PubMed PubMed Central Google Scholar
Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404–12.
Pan-American Health Organization. HPV Tests For Cervical Cancer Screening. 2016. https://www3.paho.org/hq/index.php?option=com_content&view=article&id=11925:hpv-tests-for-cervical-cancer-screening&Itemid=41948&limitstart=1〈=en#gsc.tab=0.%20Retrieved%2020%20September%202022.
Arbyn M, Simon M, Peeters E, Xu L, Meijer CJLM, Berkhof J, et al. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect. 2021;27(8):1083–95.
Article CAS PubMed Google Scholar
The Economist Intelligence Unit Limited. (2021). Global action on financing cervical cancer elimination: Funding secondary prevention services in low resource settings. https://www.uicc.org/sites/main/files/atoms/files/eiu_uicc_global_action_on_financing_cervical_cancer_elimination.pdf. Accessed 01 Feb 2023.
Abreu ALP, Souza R, Gimenes F, Consolaro MEL. A review of methods for detect human Papillomavirus infection. Virol J. 2012;9:262–262.
Article CAS PubMed PubMed Central Google Scholar
Salazar KL, Duhon D, Olsen R, Thrall M. A review of the FDA-approved molecular testing platforms for human papillomavirus. J Am Soc Cytopathol. 2019;8(5):284–92.
Sayed S, Chung M, Temmerman M. Point-of-care HPV molecular diagnostics for a test-and-treat model in high-risk HIV populations. Lancet Glob Health. 2020;8(2):E171-172.
Luckett R, Mogowa N, Li HJ, Erlinger A, Hacker MR, Esselen K, et al. Performance of two-stage cervical cancer screening with primary high-risk human papillomavirus testing in women living with human immunodeficiency virus. Obstet Gynecol. 2019;134(4):840–9.
Article CAS PubMed PubMed Central Google Scholar
Makhema J, Wiirth KE, Holme MP, Gaolathe T, Mmalane M, Kadima E, et al. Universal testing, expanded treatment, and incidence of HIV infection in Botswana. N Engl J Med. 2019;381(3):230–42.
Article PubMed PubMed Central Google Scholar
Luckett R, Painter H, Hacker MR, Simon B, Seiphetlheng A, Erlinger A, et al. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study. BJOG. 2021;128(12):1986–96.
Article CAS PubMed PubMed Central Google Scholar
Tang YW, Lozano L, Chen X, Querec T, Katabi N, Moreno-Docón A, et al. An isothermal, multiplex amplification assay for detection and genotyping of human papillomaviruses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2020;22(3):419–28.
Article CAS PubMed PubMed Central Google Scholar
Connors KA, Abbott S, Jair K, Daniels J, Lintner M, Klein D, et al. Cross comparison of AmpFire HPV genotyping assay and Roche human papillomavirus (HPV) linear array for HPV genotyping of anal swab samples. J Virol Methods. 2021;292:114113.
Article CAS PubMed PubMed Central Google Scholar
Jang D, Shah A, Arias M, Ratnam S, Smieja M, Chen X, et al. Performance of AmpFire HPV assay on neck cervical lymph node aspirate and oropharyngeal samples. J Virol Methods. 2020;279:113840.
Article CAS PubMed Google Scholar
Juliana NCA, Juma MH, Heijmans R, Ouburg S, Ali SM, Chauhan AS, et al. Detection of high-risk human papillomavirus (HPV) by the novel AmpFire isothermal HPV assay among pregnant women in Pemba Island, Tanzania. Pan Afr Med J. 2020;37:183–183.
Article PubMed PubMed Central Google Scholar
Zhang W, Du H, Huang X, Wang C, Duan X, Liu Y, et al. Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening. Infect Agent Cancer. 2020;15:65–65.
Article CAS PubMed PubMed Central Google Scholar
Kelly H, Jaafar I, Chung M, Michelow P, Greene S, Strickler H, et al. Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysis. eClinicalMedicine. 2022;53:101645.
Article PubMed PubMed Central Google Scholar
Kuhn L, Saidu R, Boa R, et al. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. Lancet Glob Health. 2020;8(2):e296–304.
Article PubMed PubMed Central Google Scholar
Stetzle D, Tanaka L, Lee KK, Khalil AI, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9:e161–9.
Garland SM, Iftner T, Cuschieri K, Kaufmann AM, Arbyn M, de Sanjose S, et al. IPVS policy statement on HPV nucleic acid testing guidance for those utilizing/considering HPV as primary precancer screening: quality assurance and quality control issues. J Clin Virol. 2023;159:105349.
Article CAS PubMed Google Scholar
Paytubi S, Taberna M, Mena M, Quirós B, Gomà M, Alemany L, et al. The isothermal amplification AmpFire assay for human papillomavirus (HPV) detection and genotyping in formalin-fixed, paraffin-embedded oropharyngeal cancer samples. J Mol Diagn. 2022;24:79–87.
Article CAS PubMed Google Scholar
Murangwa A, Desai K, Gage J, Murenzi G, Tuyisenge P, Kanyabwisha F, et al. Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda. Afr J Lab Med. 2022;11(1):a1827.
Vassilakos P, Catarino R, Bougel S, Munoz M, Benski C, Meyer-Hamme U, et al. Use of swabs for dry collection of self-samples to detect human papillomavirus among Malagasy women. Infect Agent Cancer. 2016;11:13.
Article PubMed PubMed Central Google Scholar
Chun-Qing L, Zeng X, Cui JF, Liao GD, Wu ZN, Qian-Qian G, et al. Stability study of cervical specimens collected by swab and stored dry followed by human papillomavirus DNA detection using the Cobas 4800 test. J Clin Microbiol. 2017;55(2):568–73.
Goldstein A, Lei Y, Goldstein L, Goldstein A, Bai QX, Felix J, et al. A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing. Infect Ag Cancer. 2020;15:64.
Patel R, Tsalik E, Evans S, Fowler V, Boernberg S. Clinicallly adjudicated reference standards for evaluation of infectious diseases diagnostics. Clin Infect Dis (2022); Epub ahead of print.
Chikere CMU, Wilson K, Allen AJ, Vale L. Comparative diagnostic accuracy studies with an imperfect reference standard: a comparison of correction methods. BMC Med Res Methodol. 2021;21(1):67.
留言 (0)